Invariant natural killer T-cell neutralization is a possible novel therapy for human eosinophilic esophagitis

Clinical and Translational Immunology

Volumn 3, Issue 1, 2014, Pages

  Rayapudi, Madhavi ^a   Rajavelu, Priya ^b   Zhu, Xiang ^b   Kaul, Ajay ^b   Niranjan, Rituraj ^c   Dynda, Scott ^c   Mishra, Akanksha ^d   Mattner, Jochen ^b,e   Zaidi, Asifa ^f   Dutt, Parmesh ^f   Mishra, Anil ^f  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d Case Western Reserve University   (United States)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^f TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

anti CD1d; anti V 24J 18; CXCL16; iNKT cells; PBS57

Indexed keywords

EID: 85095667903     PISSN: None     EISSN: 20500068     Source Type: Journal    
DOI: 10.1038/cti.2013.13     Document Type: Article

References (61)

1. Noel RJ, Putnam PE, Collins MH, Assa'ad AH, Guajardo JR, Jameson SC et al. Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol 2004; 2: 568–575.
2. Rothenberg ME. Eosinophilia. N Engl J Med 1998; 338: 1592–1600.
3. Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol 2004; 113: 11–28.
4. Mishra A, Rothenberg ME. Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism. Gastroenterology 2003; 125: 1419–1427.
5. Akei HS, Mishra A, Blanchard C, Rothenberg ME. Epicutaneous antigen exposure primes for experimental eosinophilic esophagitis in mice. Gastroenterology 2005; 129: 985–994.
6. Mishra A, Hogan SP, Brandt EB, Rothenberg ME. IL-5 promotes eosinophil trafficking to the esophagus. J Immunol 2002; 168: 2464–2469.
7. Mishra A, Hogan SP, Brandt EB, Rothenberg ME. An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest 2001; 107: 83–90.
8. Bendelac A, Bonneville M, Kearney JF. Autoreactivity by design: innate B and T lymphocytes. Nat Rev Immunol 2001; 1: 177–186.
9. Taniguchi M, Harada M, Kojo S, Nakayama T, Wakao H. The regulatory role of Valpha14 NKT cells in innate and acquired immune response. Annu Rev Immunol 2003; 21: 483–513.
10. Wilson SB, Delovitch TL. Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity. Nat Rev Immunol 2003; 3: 211–222.
11. Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol 2005; 23: 877–900.
12. Taniguchi M, Tashiro T, Dashtsoodol N, Hongo N, Watarai H. The specialized iNKT cell system recognizes glycolipid antigens and bridges the innate and acquired immune systems with potential applications for cancer therapy. Int Immunol 2010; 22: 1–6.
13. Kerzerho J, Yu ED, Barra CM, Alari-Pahissa E, Girardi E, Harrak Y et al. Structural and functional characterization of a novel nonglycosidic type I NKT agonist with immunomodulatory properties. J Immunol 2012; 188: 2254–2265.
14. Montoya CJ, Pollard D, Martinson J, Kumari K, Wasserfall C, Mulder CB et al. Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11. Immunology 2007; 122: 1–14.
15. Sobirin MA, Kinugawa S, Takahashi M, Fukushima A, Homma T, Ono T et al. Activation of natural killer T cells ameliorates postinfarct cardiac remodeling and failure in mice. Circ Res 2012; 111: 1037–1047.
16. Wingender G, Rogers P, Batzer G, Lee MS, Bai D, Pei B et al. Invariant NKT cells are required for airway inflammation induced by environmental antigens. J Exp Med 2011; 208: 1151–1162.
17. Gadue P, Stein PL. NK T cell precursors exhibit differential cytokine regulation and require Itk for efficient maturation. J Immunol 2002; 169: 2397–2406.
18. Pellicci DG, Hammond KJ, Uldrich AP, Baxter AG, Smyth MJ, Godfrey DI. A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage. J Exp Med 2002; 195: 835–844.
19. Watarai H, Sekine-Kondo E, Shigeura T, Motomura Y, Yasuda T, Satoh R et al. Development and function of invariant natural killer T cells producing T(h)2- and T(h)17-cytokines. PLoS Biol 2012; 10: e1001255.
20. Yoshiga Y, Goto D, Segawa S, Ohnishi Y, Matsumoto I, Ito S et al. Invariant NKT cells produce IL-17 through IL-23-dependent and -independent pathways with potential modulation of Th17 response in collagen-induced arthritis. Int J Mol Med 2008; 22: 369–374.
21. Sakuishi K, Oki S, Araki M, Porcelli SA, Miyake S, Yamamura T. Invariant NKT cells biased for IL-5 production act as crucial regulators of inflammation. J Immunol 2007; 179: 3452–3462.
22. Akbari O. The role of iNKT cells in development of bronchial asthma: a translational approach from animal models to human. Allergy 2006; 61: 962–968.
23. Meyer EH, DeKruyff RH, Umetsu DT. iNKT cells in allergic disease. Curr Top Microbiol Immunol 2007; 314: 269–291.
24. Meyer EH, Wurbel MA, Staton TL, Pichavant M, Kan MJ, Savage PB et al. iNKT cells require CCR4 to localize to the airways and to induce airway hyperreactivity. J Immunol 2007; 179: 4661–4671.
25. Oki S, Miyake S. Invariant natural killer T (iNKT) cells in asthma: a novel insight into the pathogenesis of asthma and the therapeutic implication of glycolipid ligands for allergic diseases. Allergol Int 2007; 56: 7–14.
26. Iwamura C, Nakayama T. Role of NKT cells in allergic asthma. Curr Opin Immunol 2010; 22: 807–813.
27. Zhu X, Wang M, Mavi P, Rayapudi M, Pandey AK, Kaul A et al. Interleukin-15 expression is increased in human eosinophilic esophagitis and mediates pathogenesis in mice. Gastroenterology 2010; 139: 182–193, e187.
28. Rayapudi M NS, Rajavelu P, Moffitt M, Mishra A, Rothenberg ME, Mishra A. Significance of esophageal local lymph nodes in food allergen-induced iNKT cell-mediated experimental eosinophilic esophagitis. AJP-Gasteroenterology 2011; 302: G645–G654.
29. Liacouras CA, Spergel JM, Ruchelli E, Verma R, Mascarenhas M, Semeao E et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol 2005; 3: 1198–1206.
30. Liacouras CA. Eosinophilic esophagitis: treatment in 2005. Curr Opin Gastroenterol 2006; 22: 147–152.
31. Faubion Jr WA, Perrault J, Burgart LJ, Zein NN, Clawson M, Freese DK. Treatment of eosinophilic esophagitis with inhaled corticosteroids. J Pediatr Gastroenterol Nutr 1998; 27: 90–93.
32. M A. Molecular mechanism for anticytokine treatments for EE. J Ped Gastro Nut 2007; 45: 383–385.
33. Mishra A, Wang M, Pemmaraju VR, Collins MH, Fulkerson PC, Abonia JP et al. Esophageal remodeling develops as a consequence of tissue specific iL-5-induced eosinophilia. Gastroenterology 2008; 134: 204–214.
34. Stein ML, Collins MH, Villanueva JM, Kushner JP, Putnam PE, Buckmeier BK et al. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol 2006; 118: 1312–1319.
35. Blanchard C, Wang N, Stringer KF, Mishra A, Fulkerson PC, Abonia JP et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 2006; 116: 536–547.
36. Niranjan RRM, Mishra A, Dutt P, Mishra A. Pathogenesis of allergen-induced eosinophilic esophagitis is independent of Interleukin (IL)-13. Immonol Cell Biol 2013; 91: 408–415.
37. Kennedy MK, Glaccum M, Brown SN, Butz EA, Viney JL, Embers M et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 2000; 191: 771–780.
38. Fan DS, Ogawa M, Fujimoto KI, Ikeguchi K, Ogasawara Y, Urabe M et al. Behavioral recovery in 6-hydroxydopamine-lesioned rats by cotransduction of striatum with tyrosine hydroxylase and aromatic L-amino acid decarboxylase genes using two separate adeno-associated virus vectors. Hum Gene Ther 1998; 9: 2527–2535.
39. Waldmann TA, Tagaya Y. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immunol 1999; 17: 19–49.
40. Jiang X, Shimaoka T, Kojo S, Harada M, Watarai H, Wakao H et al. Cutting edge: critical role of CXCL16/CXCR6 in NKT cell trafficking in allograft tolerance. J Immunol 2005; 175: 2051–2055.
41. Geissmann F, Cameron TO, Sidobre S, Manlongat N, Kronenberg M, Briskin MJ et al. Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol 2005; 3: e113.
42. Zhu X, Wang M, Crump CH, Mishra A. An imbalance of esophageal effector and regulatory T cell subsets in experimental eosinophilic esophagitis in mice. Am J Physiol Gastrointest Liver Physiol 2009; 297: G550–G558.
43. Nunez-Cruz S, Yeo WC, Rothman J, Ojha P, Bassiri H, Juntilla M et al. Differential requirement for the SAP-Fyn interaction during NK T cell development and function. J Immunol 2008; 181: 2311–2320.
44. Zhou D, Mattner J, Cantu C 3rd, Schrantz N, Yin N, Gao Y et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 2004; 306: 1786–1789.
45. Furuta GT, Liacouras CA, Collins MH, Gupta SK, Justinich C, Putnam PE et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007; 133: 1342–1363.
46. Rothenberg ME, Mishra A, Collins MH, Putnam PE. Pathogenesis and clinical features of eosinophilic esophagitis. J Allergy Clin Immunol 2001; 108: 891–894.
47. Mishra A. Mechanism of eosinophilic esophagitis. Immunol Allergy Clin North Am 2009; 29: 29–40.
48. Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, Bonis PA et al. Eosinophilic esophagitis: Updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011; 128: 3–20.e6.
49. Shimaoka T, Seino K, Kume N, Minami M, Nishime C, Suematsu M et al. Critical role for CXC chemokine ligand 16 (SR-PSOX) in Th1 response mediated by NKT cells. J Immunol 2007; 179: 8172–8179.
50. Kim CH JB, Butcher EC. Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among V alpha 24(+)V beta 11(+) NKT cell subsets with distinct cytokine-producing capacity. Blood 2002; 100: 11–16.
51. Lehrke M, Konrad A, Schachinger V, Tillack C, Seibold F, Stark R et al. CXCL16 is a surrogate marker of inflammatory bowel disease. Scand J Gastroenterol 2008; 43: 283–288.
52. Diegelmann J, Seiderer J, Niess JH, Haller D, Goke B, Reinecker HC et al. Expression and regulation of the chemokine CXCL16 in Crohn's disease and models of intestinal inflammation. Inflamm Bowel Dis 2010; 16: 1871–1881.
53. Olszak T, An D, Zeissig S, Vera MP, Richter J, Franke A et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 2012; 336: 489–493.
54. Wingender G, Stepniak D, Krebs P, Lin L, McBride S, Wei B et al. Intestinal microbes affect phenotypes and functions of invariant natural killer T cells in mice. Gastroenterology 2012; 143: 418–428.
55. Mishra A, Schlotman J, Wang M, Rothenberg ME. Critical role for adaptive T cell immunity in experimental eosinophilic esophagitis in mice. J Leukoc Biol 2007; 81: 916–924.
56. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 1997; 278: 1626–1629.
57. Jyonouchi S, Abraham V, Orange JS, Spergel JM, Gober L, Dudek E et al. Invariant natural killer T cells from children with versus without food allergy exhibit differential responsiveness to milk-derived sphingomyelin. J Allergy Clin Immunol 2011; 128: 102–109, e113.
58. Arora AS, Perrault J, Smyrk TC. Topical corticosteroid treatment of dysphagia due to eosinophilic esophagitis in adults. Mayo Clin Proc 2003; 78: 830–835.
59. Rajavelu P, Rayapudi M, Moffitt M, Mishra A, Mishra A. Significance of para-esophageal lymph nodes in food or aeroallergen-induced iNKT cell-mediated experimental eosinophilic esophagitis. Am J Physiol Gastrointest Liver Physiol 2012; 302: G645–G654.
60. Tohyama M, Sayama K, Komatsuzawa H, Hanakawa Y, Shirakata Y, Dai X et al. CXCL16 is a novel mediator of the innate immunity of epidermal keratinocytes. Int Immunol 2007; 19: 1095–1102.
61. Mattner J, Debord KL, Ismail N, Goff RD, Cantu C 3rd, Zhou D et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 2005; 434: 525–529.